The aims of this study will be to evaluate the effect of motivational interviewing (MI) to improve self-care in heart failure (HF) patients and caregiver contributions to HF self-care. Also this study will evaluate the effect of MI on the following secondary outcomes: In HF patients: HF somatic symptom perception, generic and specific quality of life, anxiety and depression, sleep quality, mutuality with caregiver, hospitalizations, use of emergency services, and mortality; In caregivers: generic quality of life, anxiety and depression, mutuality with patient, preparedness, social support and sleep quality.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
510
The intervention will consist of a brief session of motivational interviewing (MI) performed by a trained nurse. During MI, the interventionist will address one or two aspects of self-care that the participants want to address. After this first intervention, the same interventionist will contact the participant by telephone to improve the first intervention and provide further support as needed. These telephone contact will be done three times at two week intervals following the first intervention (for a total of two months). Patients and caregivers that receive the intervention also will be given informational material on HF management that is consistent with international guidelines.
University of Rome Tor Vergata
Rome, Italy
Self-care Maintenance in Patients
Self-care in HF patients will be measured with the Self-Care of HF Index V.6.2. Since this instrument has three separate scales, we considered as a primary outcome the score of the Self-care Maintenance scale. The Self-Care Maintenance scale has a score between 0 and 100 with higher score meaning better self-care. Self-Care Maintenance is considered adequate when the score is at least 70.
Time frame: 3 months from the intervention
Burden of HF Symptoms in Patients
Burden of HF symptoms will be measured with the Heart Failure Somatic Perception Scale (HFSPS). The HFSPS has a range score between 0 and 90; the higher the score, the higher the burden of symptoms caused by heart failure.
Time frame: 3, 6, 9 and 12 months from the intervention
Patient and Caregiver Generic Physical and Mental Quality of Life
Patient and caregiver generic physical and mental quality of life will be assessed with the Short Form 12 (SF-12).
Time frame: 3, 6, 9 and 12 months from the intervention
Patient and Caregiver Anxiety and Depression
Patient and caregiver anxiety and depression will be evaluated with the Hospital Anxiety and Depression Scale
Time frame: 3, 6, 9 and 12 months from the intervention
Patient HF Specific Quality of Life
Patient HF specific quality of life will be evaluated with the Kansas City Cardiomyopathy Questionnaire
Time frame: 3, 6, 9 and 12 months from the intervention
Patient and Caregiver Quality of Nocturnal Sleep
We will use the Pittsburgh Sleep Quality Index
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 3, 6, 9 and 12 months from the intervention
Patient and Caregiver Mutuality
We will use the Mutuality Scale
Time frame: 3, 6, 9 and 12 months from the intervention
Caregiver Preparedness
Caregiver Preparedness will be evaluated with the Caregiver Preparedness Scale
Time frame: 3, 6, 9 and 12 months from the intervention
Caregiver Perceived Social Support
We will use the Multidimensional Scale of Perceived Social Support Scale
Time frame: 3, 6, 9 and 12 months from the intervention
Patient Hospitalizations
The number of patient hospitalizations will be measured asking the caregiver how many time the patient was hospitalized from at 3, 6, 9 and 12 months from the intervention.
Time frame: 3, 6, 9 and 12 months from the intervention
Use of Emergency Services
How many times the patient has used the emergency services will be evaluated by asking the caregiver how many time the patient used after 3, 6, 9 and 12 months from the intervention.
Time frame: 3, 6, 9 and 12 months from the intervention
Death
Death rates will be evaluated in the three arms of the study by caregiver interview at 3, 6, 9 and 12 months from the intervention.
Time frame: 3, 6, 9 and 12 months from the intervention